Your browser doesn't support javascript.
[Mechanism of Qingfei Paidu decoction for treatment of COVID-19: analysis based on network pharmacology and molecular docking technology].
Yan, Haiyan; Zou, Yan; Zou, Chuncai.
  • Yan H; School of Pharmacy, Wannan Medical College, Wuhu 241002, China.
  • Zou Y; School of Chemical Science and Technology/School of Pharmacy, Yunnan University, Kunming 650091, China.
  • Zou C; School of Pharmacy, Wannan Medical College, Wuhu 241002, China.
Nan Fang Yi Ke Da Xue Xue Bao ; 40(5): 616-623, 2020 May 30.
Article in Chinese | MEDLINE | ID: covidwho-750377
ABSTRACT

OBJECTIVE:

To explore the target, signaling pathways and their biological functions of Qingfei Paidu Decoction in the treatment of COVID-19 based on network pharmacology and molecular docking technology.

METHODS:

The active components and target proteins in 21 drugs such as Ephedrae Herba and Pinelliae Rhizoma in Qingfei Paidu decoction were analyzed, and the signaling pathways and biological functions of the target proteins common with COVID-19 were screened by using TCMSP, Swiss Target Prediction, CooLGeN, GeneCards, DAVID and other databases. The network diagram of Qingfei Paidu decoction was constructed using Gephi software.

RESULTS:

We identified 163 active ingredients, including MOL004798, MOL000519, MOL004824, MOL000554, MOL010428, and MOL013443, from 18 drugs in Qingfei Paidu decoction (such as Ephedrae Herba, Pinelliae Rhizoma, Glycyrrhizae Radix Et Rhiizoma, Farfarae Flos, Asteris Radix Et Rhizoma and Aurantii Fructus Immaturus). These ingredients activate renin-angiotensin system signaling pathway and apoptosis signaling pathway by regulating 10 protein targets (ACE, ACE2, AGTR1, FURIN, TNF, CASP3, CASP6, DPP4, MCL1 and POLD1) to execute 42 biological functions such as renin-angiotensin regulation of blood volume and systemic arterial blood pressure to treat COVID-19. The results of preliminary molecular docking showed that MOL000519 (from Pinelliae Rhizoma), MOL000554 (from Farfarae Flos), MOL004798 (from Ephedrae Herba), MOL004824 (from Glycyrrhizae Radix Et Rhiizoma), MOL010428 (from Asteris Radix Et Rhizoma), and MOL013443 (from Aurantii Fructus Immaturus) had good affinity with SARS-CoV-2 3CL hydrolase to form complexes with stable conformations and high binding activity (binding energy ≤- 5 kJ/mol).

CONCLUSIONS:

Qingfei Paidu decoction can treat COVID-19 through its multiple medicinal ingredients that have multiple targets and involve multiple signaling pathways for different biological functions. Our finding provides reference for further investigation into the pharmacological mechanism of Qingfei Paidu decoction in treating COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drugs, Chinese Herbal / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Prognostic study Topics: Traditional medicine Limits: Humans Language: Chinese Journal: Nan Fang Yi Ke Da Xue Xue Bao Year: 2020 Document Type: Article Affiliation country: J.issn.1673-4254.2020.05.02

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Drugs, Chinese Herbal / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Prognostic study Topics: Traditional medicine Limits: Humans Language: Chinese Journal: Nan Fang Yi Ke Da Xue Xue Bao Year: 2020 Document Type: Article Affiliation country: J.issn.1673-4254.2020.05.02